Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C10H12N2 |
Molecular Weight | 160.2157 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C1N[C@@H](CC=C1)C2=CN=CC=C2
InChI
InChIKey=SOPPBXUYQGUQHE-JTQLQIEISA-N
InChI=1S/C10H12N2/c1-2-7-12-10(5-1)9-4-3-6-11-8-9/h1-4,6,8,10,12H,5,7H2/t10-/m0/s1
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1907594 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18187282 |
|||
Target ID: GO:0006954 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23178521 |
PubMed
Title | Date | PubMed |
---|---|---|
Gas chromatographic-mass spectrometric method for determination of anabasine, anatabine and other tobacco alkaloids in urine of smokers and smokeless tobacco users. | 1993 Sep 8 |
|
Nicotine-related alkaloids and metabolites as inhibitors of human cytochrome P-450 2A6. | 2004 Feb 15 |
|
The addition of five minor tobacco alkaloids increases nicotine-induced hyperactivity, sensitization and intravenous self-administration in rats. | 2009 Nov |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C221
Created by
admin on Fri Dec 15 19:36:43 GMT 2023 , Edited by admin on Fri Dec 15 19:36:43 GMT 2023
|
||
|
DSLD |
213 (Number of products:11)
Created by
admin on Fri Dec 15 19:36:43 GMT 2023 , Edited by admin on Fri Dec 15 19:36:43 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000182814
Created by
admin on Fri Dec 15 19:36:43 GMT 2023 , Edited by admin on Fri Dec 15 19:36:43 GMT 2023
|
PRIMARY | |||
|
SUB197096
Created by
admin on Fri Dec 15 19:36:43 GMT 2023 , Edited by admin on Fri Dec 15 19:36:43 GMT 2023
|
PRIMARY | |||
|
DTXSID901016110
Created by
admin on Fri Dec 15 19:36:43 GMT 2023 , Edited by admin on Fri Dec 15 19:36:43 GMT 2023
|
PRIMARY | |||
|
11388
Created by
admin on Fri Dec 15 19:36:43 GMT 2023 , Edited by admin on Fri Dec 15 19:36:43 GMT 2023
|
PRIMARY | |||
|
5PP654XB7D
Created by
admin on Fri Dec 15 19:36:43 GMT 2023 , Edited by admin on Fri Dec 15 19:36:43 GMT 2023
|
PRIMARY | |||
|
ANATABINE
Created by
admin on Fri Dec 15 19:36:43 GMT 2023 , Edited by admin on Fri Dec 15 19:36:43 GMT 2023
|
PRIMARY | |||
|
m1890
Created by
admin on Fri Dec 15 19:36:43 GMT 2023 , Edited by admin on Fri Dec 15 19:36:43 GMT 2023
|
PRIMARY | Merck Index | ||
|
C012737
Created by
admin on Fri Dec 15 19:36:43 GMT 2023 , Edited by admin on Fri Dec 15 19:36:43 GMT 2023
|
PRIMARY | |||
|
C114277
Created by
admin on Fri Dec 15 19:36:43 GMT 2023 , Edited by admin on Fri Dec 15 19:36:43 GMT 2023
|
PRIMARY | NCIT | ||
|
581-49-7
Created by
admin on Fri Dec 15 19:36:43 GMT 2023 , Edited by admin on Fri Dec 15 19:36:43 GMT 2023
|
PRIMARY |
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD